Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice

被引:93
|
作者
Yang, Zhigang
Chen, Aqin
Sun, Hongxiang
Ye, Yiping
Fang, Weihuan
机构
[1] Zhejiang Univ, Coll Anim Sci, Hangzhou 310029, Zhejiang, Peoples R China
[2] Zhejiang Acad Med Sci, Inst Mat Med, Hangzhou 310013, Peoples R China
[3] Shanghai Fisheries Univ, Coll Aqua Life Sci & Technol, Shanghai 200090, Peoples R China
关键词
Panax notoginseng; ginsenoside Rd; adjuvanticity; cytokines;
D O I
10.1016/j.vaccine.2006.05.075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ginsenoside Rd (Rd), a saponin isolated from the roots of panax notoginseng, was evaluated for inducing Th1 or Th2 immune responses in mice against ovalbumin (OVA). ICR mice were immunized subcutaneously with OVA 100 mu g alone or with OVA 100 mu g dissolved in saline containing alum (200 mu g), or Rd (10, 25 or 50 mu g) on days 1 and 15. Two weeks later (day 28), concanavalin A (Con A)-, lipopolysaccharide (LPS)- and OVA-stimulated splenocyte proliferation was determined using MTT assay, and OVA-specific antibody titers and levels of cytokines in serum were measured by ELISA and microparticle-based flow cytometric immunoassay, as well as peripheral blood T-lymphocyte subsets analyzed using flow cytometer. Rd significantly enhanced the Con A-, LPS-, and OVA-induced splenocyte proliferation in the OVA-immunized mice. OVA-specific IgG, IgG 1, and 1gG2b antibody titers in serum were significantly enhanced by Rd compared with OVA control group. Meanwhile, Rd also significantly promoted the production of the Th1 and Th2 cytokines in OVA-immunized mice. Further, the effects of Rd on expression of cytokine rnRNA in Con A-stimulated mice splenocytes were evaluated by RT-PCR analysis. Rd significantly enhanced the interleukin-2 (IL-2), interferon-gamma (IFN-gamma), IL-4, and IL-10 mRNA expression in mice splenocyte induced by Con A. These results suggested that Rd had immunological adjuvant activity, and elicited a Th1 and Th2 immune response by regulating production and gene expression of Th1 cytokines and Th2 cytokines. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 50 条
  • [41] Regulation of immune response: The TH1/TH2 concept
    Pichler, WJ
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 127 (09) : 341 - 348
  • [42] Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4
    Tominaga, N
    Ohkusu-Tsukada, K
    Udono, H
    Abe, R
    Matsuyama, T
    Yui, K
    INTERNATIONAL IMMUNOLOGY, 2003, 15 (01) : 1 - 10
  • [43] Th1 and Th2 cytokine responses to academic stress
    Kang, DH
    Fox, C
    RESEARCH IN NURSING & HEALTH, 2001, 24 (04) : 245 - 257
  • [44] Redirecting Th1 and Th2 responses in autoimmune disease
    Pearson, CI
    McDevitt, HO
    REDIRECTION OF TH1 AND TH2 RESPONSES, 1999, 238 : 79 - 122
  • [45] Th1 vs Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
    Jabs, DA
    Lee, B
    Whittum-Hudson, J
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S138 - S138
  • [46] Th1/Th2 lymphocyte responses in Helicobacter infections
    Nedrud, JG
    Mohammadi, M
    Blanchard, T
    Redline, R
    Czinn, SJ
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 1998, 1998, : 101 - 109
  • [47] Science commentary: Th1 and Th2 responses: what are they?
    Berger, A
    BRITISH MEDICAL JOURNAL, 2000, 321 (7258): : 424 - 424
  • [48] Th1/Th2 responses to Nontypable Haemophilus influenzae
    King, PT
    Hutchinson, P
    Holmes, P
    Freezer, N
    Johnson, P
    Holdsworth, S
    FASEB JOURNAL, 2002, 16 (04): : A300 - A300
  • [49] Isoorientin alleviates ovalbumin-stimulated allergic rhinitis in mice by restoring Th1/Th2 balance
    Huang, Jianyi
    Ji, Ran
    Qian, Xueshen
    Shen, Yuli
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2024, 52 (05) : 29 - 35
  • [50] Myricetin alleviates ovalbumin-induced allergic rhinitis in mice by regulating Th1/Th2 balance
    Shi, Ya-Nan
    Su, Jin-Zhu
    Wang, Juan
    Geng, Jiang-Qiao
    ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, 2023, 13 (07) : 306 - 314